@article {479,
	title = {Granulocyte-macrophage colony-stimulating factor improves immunological parameters in patients with refractory solid tumours receiving second-line chemotherapy: correlation with clinical responses},
	journal = {Eur J Cancer},
	volume = {33},
	number = {8},
	year = {1997},
	pages = {1202-8},
	type = {Journal Article},
	abstract = {{In this report, we studied the immunorestorative properties of subcutaneously administered granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with refractory solid tumours receiving second-line chemotherapy. Such patients exhibit abnormal immune responses in vivo and in vitro and, therefore, it was of interest to examine the effect of GM-CSF-induced immunomodulation on clinical response. We examined patients with primary malignant carcinomas (head and neck},
	keywords = {Adult Aged Antineoplastic Combined Chemotherapy Protocols Carboplatin Cytokines Cytotoxicity, Immunologic Female Fluorouracil Granulocyte-Macrophage Colony-Stimulating Factor Humans Killer Cells, Lymphokine-Activated Killer Cells, Mixed Male Middle Aged Neoplasms, Natural Lymphocyte Culture Test},
	issn = {0959-8049},
	url = {http://www.ncbi.nlm.nih.gov/pubmed/9301443},
	author = {Baxevanis, C. N. and Tsavaris, N. B. and Papadhimitriou, S. I. and Zarkadis, I. K. and Papadopoulos, N. G. and Bastounis, E. A. and Papamichail, M.}
}
